Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated “Big Bang” pathway to CRC in three of the four Lynch syndromes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,23 MB, PDF-dokument

  • Pål Møller
  • Saskia Haupt
  • Aysel Ahadova
  • Matthias Kloor
  • Julian R. Sampson
  • Toni Seppälä
  • John Burn
  • Inge Bernstein
  • Gabriel Capella
  • D. Gareth Evans
  • Annika Lindblom
  • Ingrid Winship
  • Finlay Macrae
  • Lior Katz
  • Ido Laish
  • Elez Vainer
  • Kevin Monahan
  • Elizabeth Half
  • Karoline Horisberger
  • Leandro Apolinário da Silva
  • Vincent Heuveline
  • Christina Therkildsen
  • Charlotte Lautrup
  • Giulia Martina Cavestro
  • Gabriela Möslein
  • Eivind Hovig
  • Mev Dominguez-Valentin
Background
Colorectal cancers (CRCs) in the Lynch syndromes have been assumed to emerge through an accelerated adenoma-carcinoma pathway. In this model adenomas with deficient mismatch repair have an increased probability of acquiring additional cancer driver mutation(s) resulting in more rapid progression to malignancy. If this model was accurate, the success of colonoscopy in preventing CRC would be a function of the intervals between colonoscopies and mean sojourn time of detectable adenomas. Contrary to expectations, colonoscopy did not decrease incidence of CRC in the Lynch syndromes and shorter colonoscopy intervals have not been effective in reducing CRC incidence. The prospective Lynch Syndrome Database (PLSD) was designed to examine these issues in carriers of pathogenic variants of the mis-match repair (path_MMR) genes.

Materials and methods
We examined the CRC and colorectal adenoma incidences in 3,574 path_MLH1, path_MSH2, path_MSH6 and path_PMS2 carriers subjected to regular colonoscopy with polypectomy, and considered the results based on sojourn times and stochastic probability paradigms.

Results
Most of the path_MMR carriers in each genetic group had no adenomas. There was no association between incidences of CRC and the presence of adenomas. There was no CRC observed in path_PMS2 carriers.

Conclusions
Colonoscopy prevented CRC in path_PMS2 carriers but not in the others. Our findings are consistent with colonoscopy surveillance blocking the adenoma-carcinoma pathway by removing identified adenomas which might otherwise become CRCs. However, in the other carriers most CRCs likely arised from dMMR cells in the crypts that have an increased mutation rate with increased stochastic chaotic probabilities for mutations. Therefore, this mechanism, that may be associated with no or only a short sojourn time of MSI tumours as adenomas, could explain the findings in our previous and current reports.
OriginalsprogEngelsk
Artikelnummer6
TidsskriftHereditary Cancer in Clinical Practice
Vol/bind22
Udgave nummer1
Antal sider12
ISSN1731-2302
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
DGE is funded by the Manchester National Institute for Health Research (NIHR) Biomedical Research Centre (IS-BRC-1215-20007), IS-BRC-1215-20007.

Funding Information:
PM, EH and MD-V received a grant from The Norwegian Cancer Society, Contract 194751-2017. TTS received grants from.

Publisher Copyright:
© The Author(s) 2024.

ID: 392570640